Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,669.5
8.1 (0.30%)

 

  • STI Straits Times Index
    2,669.5
    8.1 (0.30%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.5
    16.8 (1.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,129.2
    153.5 (0.59%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,403.4
    58.1 (1.74%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,438.7
    -176.0 (-0.78%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,076.2
    89.1 (1.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,868.5M
  • Value: 1,016.3M
  • Rise: 197
  • Fall: 137
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.133+0.014
AsiaMedic0.020+0.005
Medtecs Intl0.820+0.115
SinoCloud0.001-0.001
Ntegrator Intl0.010+0.001
Wilton Resources0.038+0.005
TEE Intl0.033+0.003
Spackman0.010-0.001
BlackGoldNatural0.018+0.002
Healthway Med0.035+0.004

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HUAKANG BIOMED HUAKANG BIOMED
Quotes 15 Minutes Delayed. Updated at 08 Jul 2020 16:08
Last (HKD): 0.104 Change: -0.006 High: 0.120 Remarks: -
Change (%): -5.45 Low: 0.102
Open 0.117 Yesterday's Close 0.110
Buy Price 0.104 Sell Price 0.120
Buy Volume ('000) 120 Sell Volume ('000) 96
Cumulative Volume ('000) 328 Cumulative Value 38,976
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -0.00081 Trailing EPS (HKD) e -0.00081 NAV (HKD) b 0.1977
PE a - Trailing PE f - Price / NAV b 0.5260
Dividend (HKD) d - Cash In Hand (HKD) g 0.1364 Issued & Paid-up Shares c 400,000,000
Dividend Yield (%) d - Price / Cash In Hand g 0.762 Treasury Shares h -
Beta - 75 Daysi 0.633 R-Squared - 75 Days(%)i 5.14 Market Cap (M) 41.600
Beta - 500 Daysi 0.125 R-Squared - 500 Days (%)i 0.08 Enterprise Value (M) -11.177
Piotroski F Score 2 Exchange Code 8622 Par Value ( HKD ) 0.01000
52 Weeks Volatility (%) 63.86 6-Month VWAP 0.202 Free Float (%) 31.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Dec 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 07 Dec 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HUAKANG BIOMED HKEx 41.600 - - 0.5260 -
Industry Medical Specialties HKEx 18,188.786 115.667 115.667 6.9783 0.280
Local Peer WEIGAO GROUP HKEx 86,647.843 41.420 41.420 4.7859 0.694
Local Peer MICROPORT HKEx 71,018.894 195.845 195.849 17.5611 0.121
Local Peer KANGJI MEDICAL HKEx 42,575.140 206.236 206.231 130.1186 -
Local Peer VENUS MEDTECH-B HKEx 34,662.985 - - 10.2036 -
Local Peer AK MEDICAL HKEx 30,077.190 99.349 99.348 24.0942 0.262
Local Peer PEIJIA-B HKEx 22,152.130 - - -39.6825 -
Local Peer KDL MEDICAL HKEx 11,537.000 102.138 102.139 8.4791 0.281
Local Peer LIFETECH SCI HKEx 9,993.590 68.163 68.165 7.7498 -
Local Peer CIRC HKEx 6,845.321 18.348 18.348 1.6278 0.714
Local Peer YESTAR HEALTH HKEx 2,827.395 12.303 12.303 2.1556 -
Local Peer PW MEDTECH HKEx 2,667.725 28.697 28.697 0.5175 -
Local Peer GOLDEN MEDITECH HKEx 2,333.544 - - 0.6069 -
Other Local Peers VINCENT MED (HKEx), MODERN DENTAL (HKEx), YUNNAN ENERGY (HKEx), KELFRED (HKEx), LIFE HEALTHCARE (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 163,547.871 44.612 46.213 5.4123 1.423
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 150,180.118 40.633 40.932 5.2586 0.202
Global Peer DANAHER CORP NYSE 128,965.692 51.818 47.119 4.3783 0.367
Global Peer MEDTRONIC PLC NYSE 122,956.971 25.675 25.675 2.4234 2.356
Global Peer BECTON DICKINSON & CO NYSE 71,260.951 65.860 78.309 3.4016 1.176
Global Peer STRYKER CORP NYSE 67,596.482 32.451 31.237 5.1541 1.183
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,095.000 48.644 48.399 7.8873 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,491.207 10.530 11.544 3.5853 -
Global Peer BAXTER INTERNATIONAL INC NYSE 43,505.478 43.462 42.611 5.6508 0.989
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,746.618 32.727 32.727 3.0231 1.919
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HARTA (Bursa), TOPGLOV (Bursa), STERIS PLC (NYSE), Top Glove (SGX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), CAREDX INC (NASDAQ), GLAUKOS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), HESKA CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), PROFOUND MED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), UG Healthcare (SGX), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NOVA EYE MEDICAL LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LKL (Bursa), Biolidics (SGX), CONFORMIS INC (NASDAQ), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), RESPIRI LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), MICRO-X LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), Yunnan Energy (SGX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEUROTROPE INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), DIGIRAD CORP (NASDAQ), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), STHAI (SET), ANALYTICA (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.004
-3.70 %
10 Days -+0.008
+8.33 %
20 Days --0.002
-1.89 %
Medium Term Return 3 Months --0.019
-15.45 %
6 Months --0.036
-25.71 %
1 Year --0.099
-48.77 %
Annualised Return Annualised --
-48.77 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.091 - 0.360 Change From 1 Year Low +0.013 % Change From 1 Year Low (%) +14.29
Change From 1 Year High -0.256 % Change From 1 Year High (%) -71.11
2 Years Range 0.091 - 0.540 Change From 2 Years Low +0.013 % Change From 2 Years Low (%) +14.29
Change From 2 Years High -0.436 % Change From 2 Years High (%) -80.74
5 Years Range 0.091 - 0.540 Change From 5 Years Low +0.013 % Change From 5 Years Low (%) +14.29
Change From 5 Years High -0.436 % Change From 5 Years High (%) -80.74
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The firm engages in the manufacture and sale of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents consists of male fertility IVD reagents, parasite antibody detection reagents and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Jul 2020 0.117 0.120 0.102 0.104 328,000 0.1188
07 Jul 2020 0.110 0.110 0.110 0.110 504,000 0.1100
06 Jul 2020 0.110 0.110 0.110 0.110 136,000 0.1100
03 Jul 2020 0.102 0.110 0.102 0.110 80,000 0.1064
02 Jul 2020 0.099 0.102 0.099 0.102 104,000 0.0990
30 Jun 2020 0.108 0.108 0.108 0.108 24,000 0.1080
29 Jun 2020 0.091 0.114 0.091 0.109 80,000 0.1096
26 Jun 2020 0.096 0.096 0.096 0.096 - -
24 Jun 2020 0.096 0.096 0.096 0.096 - -
23 Jun 2020 0.096 0.096 0.096 0.096 - -
22 Jun 2020 0.096 0.096 0.096 0.096 - -
19 Jun 2020 0.096 0.096 0.096 0.096 24,000 0.5960
18 Jun 2020 0.095 0.095 0.095 0.095 8,000 0.0950
17 Jun 2020 0.091 0.093 0.091 0.093 176,000 0.0929
16 Jun 2020 0.096 0.096 0.096 0.096 32,000 0.0960
15 Jun 2020 0.097 0.097 0.097 0.097 - -
12 Jun 2020 0.097 0.097 0.097 0.097 40,000 0.0970
11 Jun 2020 0.100 0.100 0.100 0.100 40,000 0.1000
10 Jun 2020 0.106 0.106 0.106 0.106 - -
09 Jun 2020 0.108 0.108 0.108 0.108 96,000 0.1080
08 Jun 2020 0.115 0.115 0.109 0.109 8,000 0.1150
05 Jun 2020 0.103 0.103 0.103 0.103 8,000 0.6030
Summary
Current 2 Weeks
(23 Jun 2020 to 08 Jul 2020)
0.096 0.120 0.091 0.104 1,256,000 -
Previous 2 Weeks
(09 Jun 2020 to 22 Jun 2020)
0.108 0.120 0.091 0.096 416,000 -
4 Weeks from
(12 May 2020 to 08 Jun 2020)
0.118 0.120 0.091 0.109 2,136,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.